DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Gaucher's Disease Pipeline Highlights - 2016 Update" drug pipelines to their offering.
The latest report provides the most up-to-date information on key pipeline products in the global Gaucher's Disease market. It covers emerging therapies for Gaucher's Disease in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and executing in-licensing and out-licensing deals.
Clinical Trial Stages:
The report provides Gaucher's Disease pipeline products by clinical trial stages including both early and late stage development - phase 3 clinical trials, phase 2 clinical trials, phase 1 clinical trials, preclinical research, and discovery stage.
Drug Mechanism Classes:
The report provides Gaucher's Disease pipeline products by their dominant mechanism of action. This helps executives categorize products based on their drug class and also assess the strengths and weaknesses of compounds.
Key Topics Covered:
1. Gaucher's Disease Pipeline by Stages
2. Gaucher's Disease Pipeline by Drug Class
3. Gaucher's Disease Pipeline by Company
4. Gaucher's Disease Phase 3 Clinical Trial Insights
5. Gaucher's Disease Phase 2 Clinical Trial Insights
6. Gaucher's Disease Phase 1 Clinical Trial Insights
7. Gaucher's Disease Preclinical Research Insights
8. Gaucher's Disease Discovery Stage Insights
10. Research Methodology
For more information about this drug pipelines report visit http://www.researchandmarkets.com/research/qjwwds/gauchers_disease